Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07276971Not ApplicableCompleted

The Safe Early Mobilization on CABG

Role: collaborator

NCT06265363Recruiting

Evaluation of the Frequency, Risk Factors, and Outcomes of ROP in Infants with a BW >1500 Grs or GA ≥33 Wks in Turkey.

Role: collaborator

NCT02814929Completed

Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey

Role: collaborator

NCT05132192Completed

Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis

Role: collaborator

All 4 trials loaded